Circulating levels of nitric oxide and vascular endothelial growth factor throughout ovine pregnancy

Journal of Physiology

Volumn 565, Issue 1, 2005, Pages 101-109

  Vonnahme, Kimberly A ^a,e   Wilson, Matthew E ^b   Li, Yun ^c   Rupnow, Heidi L ^c   Phernetton, Terrance M ^c   Ford, Stephen P ^a   Magness, Ronald R ^c,d  

^a UNIVERSITY OF WYOMING   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FETUS; FETUS DEVELOPMENT; FETUS DISEASE; FETUS OUTCOME; MULTIPLE PREGNANCY; NONHUMAN; PLACENTA CIRCULATION; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PUERPERIUM; RADIOIMMUNOASSAY; SHEEP; STATISTICAL ANALYSIS; UTERUS BLOOD FLOW; VASODILATATION; EWE; GESTATIONAL AGE; MATERNAL BLOOD; METABOLITE; PLACENTA WEIGHT;

ANIMALS; FEMALE; GESTATIONAL AGE; NITRIC OXIDE; PREGNANCY; PREGNANCY, ANIMAL; SHEEP; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 19444364936     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.082321     Document Type: Article

References (61)

1. Ahmed A, Dunk C, Kniss D & Wilkes M (1997). Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest 76, 779-791.
2. Ahmed A, Li XF, Dunk C, Whittle MJ, Rushton DI & Rollason T (1995). Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 12, 235-243.
3. Asahara T, Murohara T, Sullivan A, Silver M, Van Der Zee R, Li T, Witzenbichler B, Schatteman G & Isner JM (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967.
4. Bird IM, Di Sullivan JAT, Cale JM, Zhang L, Zheng J & Magness RR (2000). Pregnancy-dependent changes in cell signaling underlie changes in differential control of vasodilator production in uterine artery endothelial cells. Endocrinology 141, 1107-1117.
5. Borowicz PP, Arnold DR, Grazul-Bilska AT, Redmer DA & Reynolds LP (2002). Expression of vascular endothelial growth factor and its major receptors in the sheep placenta throughout the last two-thirds of pregnancy. Biol Reprod 066, (Suppl. 1), 227.
6. Brown MA, Tiben E, Zammit VC, Cario GM & Carlton MA (1995). Nitric oxide excretion in normal and hypertensive pregnancies. Hypertens Preg 14, 319-326.
7. Carnegie JA & Robertson HA (1978). Conjugated and unconjugated estrogens in fetal and maternal fluids of the pregnant ewe: a possible role for estrone sulfate during early pregnancy. Biol Reprod 19, 202-211.
8. Charnock-Jones DS, Clark DE, Licence D, Day K, Wooding FB & Smith SK (2001). Distribution of vascular endothelial growth factor (VEGF) and its binding sites at the maternal-fetal interface during gestation in pigs. Reproduction 122, 753-760.
9. Cheung CY (1997). Vascular endothelial growth factor: possible role in fetal development and placental function. J Soc Gynecol Invest 4, 169-171.
10. Cheung CY & Brace RA (1999). Developmental expression of vascular endothelial growth factor and its receptors in ovine placenta and fetal membranes. J Soc Gynecol Invest 6, 179-185.
11. Christenson RK & Prior RL (1978). Uterine blood flow and nutrient uptake during late gestation in ewes with different number of fetuses. J Anim Sci 46, 189-200.
12. Chung J-Y, Song Y, Wang Y, Magness RR & Zheng J (2004). Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF and VEGF receptors in human placentas from normal and preeclampsic pregnancies. J Clin Endocrinol Metab 89, 2484-2490.
13. Clark DE, Smith SK, Sharkey AM & Charnock-Jones DS (1996). Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. Hum Reprod 11, 1090-1098.
14. Conrad KP, Joffe GM, Kruszyna R, Kruszyna H, Rochelle LG, Smith RP, Chavez JE & Mosher MD (1993). Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 7, 566-571.
15. Cullinan-Bove K & Koos RD (1993). Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 133, 829-837.
16. Ford SP (1982). Control of uterine and ovarian blood flow throughout the estrous cycle and pregnancy of ewes, sows and cows. J Anim Sci 55, 32-42.
17. Gibson TC, Phernetton TM, Wiltbank MC & Magness RR (2004). Development and use of an ovarian synchronization model to study the effects of endogenous estrogen and nitric oxide on uterine blood flow during ovarian cycles in sheep. Biol Reprod 70, 1886-1894 (in press ePUB February 25, 2004).
18. Greiss FC Jr & Anderson SG (1970). Uterine blood flow changes during early ovine pregnancy. Am J Obstet Gynecol 106, 370-378.
19. Itoh S, Brawley L, Wheeler T, Anthony FW, Poston L & Hanson MA (2002). Vasodilation to vascular endothelial growth factor in the uterine artery of the pregnant rat is blunted by low dietary protein intake. Pediatr Res 51, 485-491.
20. Johnson ML, Redmer DA & Reynolds LP (1997). Uterine growth, cell proliferation, and c-fos proto-oncogene expression throughout the estrous cycle in ewes. Biol Reprod 56, 393-401.
21. Ku DD, Zaleski JK, Liu S & Brock TA (1993). Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol Heart Circ Physiol 265, H586-H592.
22. Kwon H, Ford SP, Bazer FW, Spencer TE, Nathanielsz PW, Nijland MJ, Hess BW & Wu G (2004a). Maternal nutrient restriction reduces concentrations of amino acids and polyamines in ovine maternal and fetal plasma and fetal fluids. Biol Reprod 71, 901-908.
23. Kwon H, Wu G, Meininger CJ, Bazer FW & Spencer TE (2004b). Developmental changes in nitric oxide synthesis in the ovine placenta. Biol Reprod 70, 679-686.
24. Magness RR (1998). Maternal cardiovascular and other physiologic responses to the endocrinology of pregnancy. In The Endocrinology of Pregnancy, ed. Bazer FW, pp. 507-539. Humana Press Inc., Totowa, NJ.
25. Magness RR, Byers MJ, King AG, Austin JL, Yi FX, Bird IM & Zheng J (2004). Estrogen receptors and VEGF modulation of angiogenic and nitric oxide respouses in ovine uterine artery endothelial cells. 37th Annual Meeting of the Society for the Study of Reproduction. (Abstract) Vancouver, BC, August 2004. Society for the Study of Reproduction, Madison, WI.
26. Magness RR, Rosenfeld CR & Carr BR (1991). Protein kinase C in uterine and systemic arteries during the ovarian cycle and pregnancy. Am J Physiol Endocrinol Metab 260, E464-E470.
27. Magness RR, Rosenfeld CR, Hassan A & Shaul PW (1996). Endothelial vasodilator production by uterine and systemic arteries I. Effect of ANG II on PGI2 and NO in pregnancy. Am J Physiol Heart Circ Physiol 270, H1914-H1923.
28. Magness RR, Shaw CE, Phernetton TM, Zheng J & Bird IM (1997). Endothelial vasodilator production by uterine and systemic arteries. II. Pregnancy effects on NO synthase expression. Am J Physiol Heart Circ Physiol 272, H1730-H1740.
29. Magness RR, Sullivan JA, Li Y, Phernetton TM & Bird IM (2001). Endothelial vasodilator production by uterine and systemic arteries. VI. Ovarian and pregnancy effects on eNOS and NOx. Am J Physiol 280, H1692-H1698.
30. Magness RR & Zheng J (1996). Maternal cardiovascular alterations during pregnancy. In Pediatrics and Perinatology, The Scientific Basics, 2nd Edn ed. Gluckman PK & Heymann MA, pp. 762-772. Arnold, London.
31. McKeeman GC, Ardill JE, Caldwell CM, Hunter AJ & McClure N (2004). Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestatin in patients who have preeclampsia develop. Am J Obstet Gynecol 191, 1240-1246.
32. Millaway DS, Redmer DA, Kirsch JD, Anthony RV & Reynolds LP (1989). Angiogenic activity of maternal and fetal placental tissues of ewes throughout gestation. J Reprod Fertil 86, 689-696.
33. Miller SL, Jenkin G & Walker DW (1999). Effect of nitric oxide synthase inhibition on the uterine vasculature of the late-pregnant ewe. Am J Obstet Gynecol 180, 1138-1145.
34. Molskness TA, Stouffer RL, Burry KA, Gorrill MJ, Lee DM & Patton PE (2004). Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and - 2, and angiogenin during ovarian stimulation in non-human primates and women. Hum Reprod 19, 822-830.
35. Nelson SH, Steinsland OD, Wang Y, Yallampalli C, Dong YL & Sanchez JM (2000). Increased nitric oxide synthase activity and expression in the human artery during pregnancy. Circ lies 87, 406-411.
36. Ni Y, May V, Braas K & Osol G (1997). Pregnancy augments uteroplacental vascular endothelial growth factor gene expression and vasodilator effects. Am J Physiol Heart Circ Physiol 273, H938-H944.
37. Nobunaga T, Tokugawa Y, Hashimoto K, Kimura T, Matsuzaki N, Nitta Y, Fujita T, Kidoguchi K, Azuma C & Saji F (1996). Plasma nitric oxide levels in pregnant patients with preedampsia and essential hypertension. Gynecol Obstet Invest 41, 189-193.
38. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, Ledda F & Ziche M (1998). Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium. J Biol Chem 272, 4220-4226.
39. Reynolds LP, Magness RR & Ford SP (1984). Uterine blood flow during early pregnancy in ewes: Interaction between the conceptus and the ovary bearing the corpus luteum. J Anim Sci 58, 423-429.
40. Reynolds LP & Redmer DA (1995). Utero-placental vascular development and placental function. J Anim Sci 73, 1839-1851.
41. Reynolds LP & Redmer DA (2001). Angiogenesis in the placenta. Biol Reprod 64, 1033-1040.
42. Rosenfeld CR (1984). Consideration of the uteroplacental circulation in intrauterine growth. Semin Perinatol 8, 42-51.
43. Rosenfeld CR, Cox BE, Roy T & Magness RR (1996). Nitric oxide contributes to estrogen-induced vasodilation of the ovine uterine circulation. J Clin Invest 98, 2158-2166.
44. Rupnow HL, Phernetton TM, Shaw GE, Modrick ML, Bird IM & Magness RR (2001). Endothelial vasodilator production by uterine and systemic arteries. VII. Estrogen and progesterone effects on eNOS. Am J Physiol Heart Circ Physiol 280, H1699-H1705.
45. Sheppard C, Li Y, Shaw CE, Bird IM & Magness RR (1997). Endothelium-derived nitric oxide synthase protein expression in ovine placental arteries. Biol Reprod 64, 1494-1499.
46. Shifren JL, Doldi N, Ferrara N, Mesiano S & Jaffe RB (1994). In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. J Clin Endocrinol Metab 79, 316-322.
47. Sladek SM, Magness RR & Conrad KP (1997). Nitric oxide and pregnancy. Am J Physiol Regul Integr Comp Physiol 272, R441-R463.
48. Stegeman JHJ (1974). Placental development in the sheep and its relation to fetal development. BiJdragen Tot Dierkunde 44, 3-72.
49. Tsoi SC, Wen Y, Chung JY, Chen D, Magness RR & Zheng J (2002). Co-expression of vascular endothelial growth factor and neuropilin-1 in ovine feto-placental artery endothelial cells. Mol Cell Endocrinol 196, 95-106.
50. van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C & Isner JM (1997). Vascular endothelial growth factor /vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95, 1030-1037.
51. Vonnahme KA & Ford SP (2004a). Placental vascular endothelial growth factor receptor system mRNA expression in pigs selected for placental efficiency. J Physiol 554, 194-201.
52. Vonnahme KA & Ford SP (2004b). Differential expression of the vascular endothelial growth factor-receptor system in the gravid uterus of Yorkshire and Meishan pigs. Biol Reprod 71, 163-169.
53. Vonnahme KA, Hess BW, Hansen TR, McCormick RJ, Rule DC, Moss GE, Murdoch WJ, Nijland MJ, Skinner DC, Nathanielsz PW & Ford SP (2003). Maternal undernutrition from early- to mid-gestation leads to growth retardation, cardiac ventricular hypertrophy, and increased liver weight in the fetal sheep. Biol Reprod 69, 133-140.
54. Vonnahme KA, Wilson ME & Ford SP (2001). Relationship between placental vascular endothelial growth factor expression and placental/endometrial vascularity in the pig. Biol Reprod 64, 1821-1825.
55. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG & Moncada S (1994). Induction of calcium-dependent nitric oxide syntheses by sex hormones. Proc Natl Acad Sci USA 91, 5212-5216.
56. Wheeler T, Evans PW, Anthony FW, Godfrey KM, Howe DT & Osmond C (1999). Relationship between maternal serum vascular endothelial growth factor concentration in early pregnancy and fetal and placental growth. Human Reprod 14, 1619-1623.
57. Williams DJ, Vallance PJ, Neild GH, Spencer JA & Imms FJ (1997). Nitric-oxide mediated vasodilation in human pregnancy. Am J Physiol Heart Circ Physiol 272, H748-H752.
58. Winther H, Ahmed A & Dantzer V (1999). Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus. Placenta 20, 35-43.
59. Yi FX, Magness RR & Bird IM (2005). Simultaneous imaging of [Ca2+]i and intracellular NO production in freshly isolated uterine artery endothelial cells: effects of ovarian cycle and pregnancy. Am J Physiol Regul Integr Comp Physiol 288, R140-R148.(Epub 2004 August 2005).
60. Zaitseva M, Yue DS, Katzenellenbogen JA, Rogers PA & Gargett CE (2004). Estrogen receptor-α agonists promote angiogenesis in human myometrial microvascular endothelial cells. J Soc Gynecol Invest 11, 529-535.
61. Zheng J, Li Y, Weiss AR, Bird IM & Magness RR (2000). Expression of endothelial and inducible nitric oxide synthases and nitric oxide production in ovine placental and uterine tissues during late pregnancy. Placenta 21, 516-524.